Proximal Versus Distal Superior Cluneal Nerve Block in Entrapment Neuropathy (NCT07372430) | Clinical Trial Compass
RecruitingNot Applicable
Proximal Versus Distal Superior Cluneal Nerve Block in Entrapment Neuropathy
Turkey (Türkiye)54 participantsStarted 2025-12-12
Plain-language summary
Superior cluneal nerve (SCN) entrapment is an underdiagnosed cause of chronic low back and gluteal pain. Although diagnostic nerve block is considered the gold standard for confirming SCN entrapment, there is no consensus regarding the optimal injection approach. This prospective observational study aims to compare the clinical effectiveness of proximal and distal ultrasound-guided SCN block techniques in patients diagnosed with SCN entrapment. Pain intensity and functional outcomes will be evaluated over the follow-up period to assess differences between the two approaches.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age between 18 and 75 years
* Chronic low back and/or gluteal pain lasting longer than 3 months
* Localized point tenderness and/or paresthesia on palpation over the unilateral posterior iliac crest
* Clinical suspicion of superior cluneal nerve entrapment based on physical examination
* Failure to respond to conservative treatment
* Ability and willingness to provide written informed consent
Exclusion Criteria:
* Active local or systemic infection
* Cognitive impairment or psychiatric disorders interfering with study participation
* History of malignancy or cancer-related pain
* Uncontrolled diabetes mellitus or severe comorbid conditions adversely affecting general health
* Pregnancy
* Known allergy to the medications used in the injection
* Prominent radicular pain associated with neurological deficit
* History of interventional procedures applied to the lumbar region within the last 6 months
* Initiation of another lumbar interventional or medical treatment during the follow-up period
* Suspected bilateral superior cluneal nerve entrapment
* Sphincter dysfunction related to neurological disease
* Bleeding diathesis or coagulation disorders
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Visual Analog Scale (VAS)
Timeframe: Baseline, 1 month, and 3 months
Trial details
NCT IDNCT07372430
SponsorGaziosmanpasa Research and Education Hospital